Description: Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and Colorado State University's College of Agricultural Sciences; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. The company was founded in 2013 and is headquartered in Louisville, Colorado.
Home Page: www.charlottesweb.com
700 Tech Court
Louisville,
CO
80027
United States
Phone:
720 484 8930
Officers
| Name | Title |
|---|---|
| Mr. William J. Morachnick | CEO & Non-Independent Director |
| Mr. Jared Stanley | Co-Founder & Director |
| Ms. Erika Lind | Chief Financial Officer |
| Mr. Raymond Kunkel | Chief Operating Officer |
| Ms. Sarah Cambridge | Corporate Controller & Chief Accounting Officer |
| Dr. Marcel Bonn-Miller Ph.D. | Chief Scientific Officer |
| Mr. Greg Gould | Chief Administration Officer |
| Mr. Cory Pala | Director of Investor Relations |
| Ms. Kelly Shea | Senior VP of Government Affairs & Corporate Communications |
| Mr. Andrew Shafer | Chief Marketing Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5052 |
| Price-to-Sales TTM: | 0.3225 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 164 |